Guyana vs Latvia: HIV-positive TB patients on ART (antiretroviral therapy)
Guyana
70.0%
in 2024
Latvia
70.0%
in 2017
Guyana rank
125th
Latvia rank
125th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Guyana
- Latvia
How they compare
Guyana currently reports 70.0% against 70.0% in Latvia, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2006 it was Latvia ahead.
Guyana ranks 125th and Latvia ranks 125th of 144 countries.
Across the 2 decades both report, Guyana averaged higher in 1 and Latvia in 1.
Head to head by decade
| Decade | Guyana | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.5% | 55.0% | 10.5% | Latvia |
| 2010s | 71.2% | 62.9% | 8.4% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Guyana or Latvia?
- Guyana, at 70.0% against 70.0% in Latvia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Guyana and Latvia?
- 0.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Latvia?
- 12 years are reported by both, from 2006 to 2017.
- How do Guyana and Latvia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Guyana ranks 125th and Latvia ranks 125th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.